|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Epstein-Barr Virus (VCA) IgG ELISA | ANGPTL8 ELISA | Anti-Ustekinumab (Stelara®) ELISA | Complement System MBL Pathway ELISA Assay | sAPPß-sw (highly sensitive) ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79861 | 27795 | TM09036 | COMPL MP320 RUO | 27733 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Epstein-Barr Virus (VCA) IgG ELISA is intended for the determination of IgG class antibodies against Epstein-Barr Virus viral capsid antigen (VCA) in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human ANGPTL8 ELISA in serum, EDTA plasma and cell culture supernatant. For research use only, not for use in diagnostic procedure | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | The Wieslab® COMPL MP320 kit is an enzyme immunoassay for the determination of MBL complement pathway in human serum. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination human sAPP_x0001_-sw in EDTA plasma of the Tg2576 transgenic mouse and cell culture supernatant. For research use only, not for use in diagnostic procedures. |
| Detection Target | Thioredoxin | NSE | sAPP Total | Human secreted Alpha Klotho (a-Klotho) | Histamine |
| Sample Type | Serum, Blood Plasma, Urine, Cell Culture Supernatant | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, EDTA-plasma, and cerebrospinal fluid (CSF). | Multiple |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 0 / 0.61 - 80 pmol/L | Anti-Ustekinumab (Stelara®) | Inquire | 0.39 to 25.00 ng/mL |
| Sensitivity | 0.43 ng/mL | Inquire | 0.06 ng/mL | 9.87 pg/mL | 0.2 ng/mL |
| Assay Time | 1 hr, 45 mins (incubation) | 2 hours total incubation time. | 2 hour, 30 min. total incubation time. | 2 hrs (incubation) | Overnight + 1 hr (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |